How will the COVID pandemic end?

In an extraordinary 20 months, science has tackled the SARS-CoV-2 virus and made vaccines for adults and children. Scientists have developed monoclonal antibodies that help if given early; we now have the first drugs that could stop infections or tilt the immunological fight in favor of the patient. The number of COVID cases is going down, although in some areas like the mountain West the disease is still raging. The virus is an opportunist. Remember the 750,000 people in the United States and the millions around the world who have died.

People go without vaccines for various reasons that we know by now. People who refuse vaccines may not understand that “Fortune favors the prepared immune system,” to paraphrase Louis Pasteur’s “Fortune favors the prepared mind.” A 50-microgram injection induces antibodies that neutralize the SARS-CoV-2 coronavirus or T-cells that kill the human cells, which contain multiplying virus.  As the vaccines’ protection wanes over six months, a few elderly people in their 80s or older have died of COVID infections. The late waning can be corrected by boosters, or at least I hope so.

The grizzly experiment to test the SARS-CoV-2 vaccines has been done in Texas, Florida, Louisiana and other places where the level of vaccination is low. The virus, or more recently the delta variant, raced through the population, filling wards with COVID patients. A year-and-a-half after this disaster hit New York hospitals, other hospitals in the West and South, Alaska and other places are converting space to treating COVID-19 patients. More than 90% of their patients in intensive care were not vaccinated. Anti-vaxxers do not usually plan clinical trials, but in this case, inadvertently, they did. The vaccine protects people.

Predicting the end of the pandemic is a tricky business. We thought we had seen the end in June and July. Then, with the delta variants, the trend reversed among unvaccinated people and cases went up. Could there be more variants? Yes, but so far, the vaccines have worked against all variants. Antibodies and T-cells react with all parts of a virus protein, not just the sections that have changed in the variants.

What does medicine have to throw into this battle?  Monoclonal antibodies are being used and they work if applied early in the disease. These antibodies are produced in fermenters and must be infused intravenously. They are expensive and tricky to use. Fighting an epidemic, especially in poor areas of the world and of the United States, demands simplicity.

There is a drug, malnupiravir, that if given early in an infection often controls it. It was developed at Emory University in Atlanta and licensed to Merck for production. Malnupiravir is a cleverly designed molecule that gets incorporated into new viruses and mutates them out of existence.  It has been approved for use in the United Kingdom. It may block infection in people who have been exposed to the virus. That will be known soon. Merck will not enforce patent restrictions.

Pfizer also has a promising drug that works by a mechanism that is different from that of malnupiravir. The difference is important because viruses often mutate to become resistant to one oral drug. In the case of HIV, several drugs were required to stop infection. Pfizer’s drug is also well along in phase 3 clinical trials and may soon receive an Emergency Use Authorization.

Excited journalists are writing about these drugs as game changers, but that is premature. A drug or combinations of drugs must have changed the game to be called a game changer. On a population basis, that remains to be seen. I am hopeful, but a little caution is in order. On a more hopeful note, drugs like these have worked for HIV, Hepatis C virus, and Dengue virus. Producing and distributing these drugs for the whole world will take time.

My prediction is that COVID-19 will recede in areas of high vaccination. All treatments will have a role, but vaccination will play the primary one. In areas where vaccination rates are low, say 40%, there will be serious problems with high levels of infection and overwhelmed medical facilities for extended periods. That patient load affects a hospital’s ability to treat other diseases. The poor and medically underserved will get even less attention. Schools, industry, and the economy are weakened. Society becomes very cranky, even violent. The vaccines, and perhaps the drugs, offer an off ramp from this disaster.

Richard Kessin lives in Norfolk and is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center. See other essays at RichardKessin.com or at The Lakeville Journal. www.tricornernews.com/category/opinion-author/body-scientific. E-mail: Richard.Kessin@gmail.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Remembering George and Anne Phillips’ Edgewood restaurant in Amenia

The Edgewood Restaurant, a beloved Amenia roadside restaurant run by George and Anne Phillips, pictured during its peak years in the 1950s and ’60s.

Provided

With the recent death of George Phillips at 100, locals are remembering the Edgewood Restaurant, the Amenia supper club he and his wife, Anne Phillips, owned and operated together for more than two decades.

At the Edgewood, there were Delmonico steaks George carved in the basement, lobster tails from an infrared cooker, local trout from the stream outside the door, and a folded paper cup of butter, with heaping bowls of family-style potatoes and vegetables, plus a shot glass of crème de menthe to calm the stomach when the modest check arrived after dessert.

Keep ReadingShow less
Artist Alissa DeGregorio brings her work to Roxbury and New Milford

Alissa DeGregorio, a New Milford -based artist and designer, has pieces on display at Mine Hill Distillery.

Agnes Fohn
When I’m designing a book, I’m also the bridge between artist and author, the final step that pulls everything together.
— Alissa DeGregorio

A visit to Alissa DeGregorio Art, the website of the artist and designer, reveals the multiple talents she possesses.

Tabs for design, commissions, print club, and classes still reveal only part of her work.On the design page are examples of graphic and book design, including book covers illustrated by DeGregorio, along with samples of licensed products such as coloring pages and lunch boxes, and examples of prop design she has done for film.

Keep ReadingShow less

Agnes Martin at Dia:Beacon

Agnes Martin at Dia:Beacon

Minimalist works by Agnes Martin on display at Dia:Beacon.

D.H. Callahan

At Dia:Beacon, simplicity commands attention.

On Saturday, April 4, the venerated modern art museum — located at 3 Beekman St. in Beacon, NY — opened an exhibition of works by the middle- to late-20th-century minimalist artist Agnes Martin.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Falls Village exhibit honors life and work of Priscilla Belcher

Hunt Library in Falls Village will present a commemorative show of paintings and etchings by the late Priscilla Belcher of Falls Village.

Lydia Downs

Priscilla Belcher, a Canaan resident who was known for her community involvement and willingness to speak out, will be featured in a posthumous exhibition at the ArtWall at the Hunt Library from April 25 through May 15.

An opening reception will be held from 5 to 7 p.m. on April 25. The show will commemorate her life and work and will include watercolors and etchings. Belcher died in November 2025 at the age of 95.

Keep ReadingShow less
Crescendo’s 'Stepping Into Song' blends Jewish, Argentine traditions

The sounds of Argentine tango and Jewish folk traditions will collide in a rare cross-cultural performance April 25 and 26, when Berkshire’s Crescendo presents the choral program “Stepping Into Song.”

Christine Gevert, Crescendo’s founding artistic director, described the concert as “a world-class, diverse cultural experience” pairing “A Jewish Cantata” with Martin Palmeri’s “Misa a Buenos Aires.”

Keep ReadingShow less
Salisbury Rotary brings Derby race-day flair to Noble Horizons for community fundraiser
Salisbury Rotary Club President Bill Pond and his wife, Beth, dressed for the occasion during last year’s Kentucky Derby Social.
Provided

SALISBURY — As millions tune in to the Kentucky Derby at Churchill Downs on May 2, a spirited local tradition unfolds in Salisbury, where the pageantry, fashion and excitement of race day are recreated — with a community purpose.

For the past six years in the Community Room at Noble Horizons, all eyes turn to the big screen as the crowd settles in, drinks in hand and anticipation building. Women in elaborate Derby hats — bursting with oversized silk flowers, feathers and playful cutouts — mingle with men dressed for the occasion in crisp jackets and bow ties, fedoras and the occasional red rose on a lapel.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.